Joseph J. Sarret joined CohBar as Chief Executive Officer and Director in May 2021.  From 2019 until 2021, Dr. Sarret worked as a consultant in the life science industry, focusing on business development and corporate development activities.  From 2015 until 2019, he served as Chief Business Officer at Corium International, Inc. (formerly NASDAQ: CORI), a biopharmaceutical company developing and commercializing transdermal healthcare products.  Prior to Corium, Dr. Sarret served in senior leadership roles at Solazyme, Inc. (formerly NASDAQ: SZYM) and Sevident, Inc.  From 2005 to 2012, he held several executive management roles, most recently serving as Chief Business Officer at Codexis, Inc. (NASDAQ: CDXS), a publicly traded life sciences company developing novel enzymes for a variety of applications.  Earlier in his career, Dr. Sarret worked as a practicing clinician focused on patients with human immunodeficiency virus and an attorney specializing in IP transactional work in the life sciences industry.  He received a B.A. in human biology from Stanford University, an M.D. from the University of California, San Francisco School of Medicine and a J.D. from Stanford Law School.